Capstone Investment Advisors’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$470K Sell
13,568
-22,429
-62% -$602K ﹤0.01% 1265
2026
Q1
$747K Buy
35,997
+26,557
+281% +$627K ﹤0.01% 967
2025
Q4
$307K Buy
+9,440
New +$404K ﹤0.01% 1337
2021
Q4
– Sell
-17,451
Closed -$132K – 1948
2021
Q3
$132K Buy
+17,451
New +$148K ﹤0.01% 1745
2021
Q2
– Sell
-11,752
Closed -$155K – 1780
2021
Q1
$155K Buy
+11,752
New +$197K ﹤0.01% 1477

Other funds holding HIMS

Capstone Investment Advisors's HIMS Position: Q2 2026 in Review

Capstone Investment Advisors reduced its Hims & Hers Health (HIMS) stake by 62% in Q2 2026, selling an estimated $602K and leaving 13,568 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #1265.

Capstone Investment Advisors first reported a position in HIMS in Q1 2021 and has held it in 5 quarters since. The position peaked at $747K in Q1 2026. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Capstone Investment Advisors held 13,568 shares of Hims & Hers Health worth $470K as of Q2 2026.
  • Capstone Investment Advisors sold 22,429 Hims & Hers Health shares in Q2 2026, an estimated $602K.
  • Hims & Hers Health made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1265 holding.
  • Capstone Investment Advisors first reported a position in Hims & Hers Health in Q1 2021 and has held it in 5 quarters since.
  • Capstone Investment Advisors's Hims & Hers Health position peaked at $747K in Q1 2026.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.